These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 34321427

  • 1. Eosinophil-Derived Neurotoxin Predicts Response to Proton-Pump Inhibitor Treatment in Pediatric Eosinophilic Esophagitis.
    Irastorza LE, Hopson P, Nabar S, Deb C, Smadi Y.
    J Pediatr Gastroenterol Nutr; 2022 Feb 01; 74(2):267-271. PubMed ID: 34321427
    [Abstract] [Full Text] [Related]

  • 2. Addressing diagnostic dilemmas in eosinophilic esophagitis using esophageal epithelial eosinophil-derived neurotoxin.
    Thomas J, Hopson P, Deb C, Bornstein J, Mehta D, Bittar K, Smadi Y.
    J Pediatr Gastroenterol Nutr; 2024 Feb 01; 78(2):304-312. PubMed ID: 38374551
    [Abstract] [Full Text] [Related]

  • 3. Longitudinal Evaluation of Noninvasive Biomarkers for Eosinophilic Esophagitis.
    Min SB, Nylund CM, Baker TP, Ally M, Reinhardt B, Chen YJ, Nazareno L, Moawad FJ.
    J Clin Gastroenterol; 2017 Feb 01; 51(2):127-135. PubMed ID: 27479142
    [Abstract] [Full Text] [Related]

  • 4. Determinant factors for first-line treatment choice and effectiveness in pediatric eosinophilic esophagitis: an analysis of the EUREOS EoE CONNECT registry.
    Navarro P, Feo-Ortega S, Casabona-Francés S, Gutiérrez-Junquera C, Savarino EV, Amorena E, Fernández-Fernández S, Pérez-Martínez I, Oliva S, Barrio J, Masiques-Mas ML, Guardiola-Arévalo A, Guagnozzi D, Racca F, Betoré E, Votto M, Rodríguez-Sánchez A, Barrio ML, Blas-Jhon L, Sánchez-Vegazo CT, García-Morales N, Krarup AL, Dainese R, Martín-Dominguez V, García-Díaz A, Maniero D, Santander C, Arias Á, Laserna-Mendieta EJ, Lucendo AJ.
    Eur J Pediatr; 2024 Aug 01; 183(8):3567-3578. PubMed ID: 38819501
    [Abstract] [Full Text] [Related]

  • 5. Blind esophageal brushing offers a safe and accurate method to monitor inflammation in children and young adults with eosinophilic esophagitis.
    Smadi Y, Deb C, Bornstein J, Safder S, Horvath K, Mehta D.
    Dis Esophagus; 2018 Dec 01; 31(12):. PubMed ID: 29905784
    [Abstract] [Full Text] [Related]

  • 6. CYP2C19 and STAT6 Variants Influence the Outcome of Proton Pump Inhibitor Therapy in Pediatric Eosinophilic Esophagitis.
    Mougey EB, Williams A, Coyne AJK, Gutiérrez-Junquera C, Fernández-Fernández S, Cilleruelo ML, Rayo A, Echeverría L, Román E, González Lois C, Chao M, Al-Atrash H, Lima JJ, Franciosi JP.
    J Pediatr Gastroenterol Nutr; 2019 Nov 01; 69(5):581-587. PubMed ID: 31490856
    [Abstract] [Full Text] [Related]

  • 7. Similarities and differences among eosinophilic esophagitis, proton-pump inhibitor-responsive esophageal eosinophilia, and reflux esophagitis: comparisons of clinical, endoscopic, and histopathological findings in Japanese patients.
    Jiao D, Ishimura N, Maruyama R, Ishikawa N, Nagase M, Oshima N, Aimi M, Okimoto E, Mikami H, Izumi D, Okada M, Ishihara S, Kinoshita Y.
    J Gastroenterol; 2017 Feb 01; 52(2):203-210. PubMed ID: 27108416
    [Abstract] [Full Text] [Related]

  • 8. Optimal Biopsy Protocol to Evaluate Histological Effectiveness of Proton Pump Inhibitor Therapy in Patients with Eosinophilic Esophagitis.
    Fujiwara Y, Hashimoto A, Uemura R, Sawada A, Otani K, Tanaka F, Yamagami H, Tanigawa T, Watanabe T, Kabata D, Kuwae Y, Shintani A, Ohsawa M.
    Digestion; 2019 Feb 01; 100(1):64-71. PubMed ID: 30408792
    [Abstract] [Full Text] [Related]

  • 9. Clinical and endoscopic characteristics do not reliably differentiate PPI-responsive esophageal eosinophilia and eosinophilic esophagitis in patients undergoing upper endoscopy: a prospective cohort study.
    Dellon ES, Speck O, Woodward K, Gebhart JH, Madanick RD, Levinson S, Fritchie KJ, Woosley JT, Shaheen NJ.
    Am J Gastroenterol; 2013 Dec 01; 108(12):1854-60. PubMed ID: 24145677
    [Abstract] [Full Text] [Related]

  • 10. Proton pump inhibitors partially restore mucosal integrity in patients with proton pump inhibitor-responsive esophageal eosinophilia but not eosinophilic esophagitis.
    van Rhijn BD, Weijenborg PW, Verheij J, van den Bergh Weerman MA, Verseijden C, van den Wijngaard RM, de Jonge WJ, Smout AJ, Bredenoord AJ.
    Clin Gastroenterol Hepatol; 2014 Nov 01; 12(11):1815-23.e2. PubMed ID: 24657840
    [Abstract] [Full Text] [Related]

  • 11. Baseline Peripheral Eosinophil Count Independently Predicts Proton Pump Inhibitor Response in Eosinophilic Esophagitis.
    Muftah M, Barshop K, Redd WD, Goldin AH, Lo WK, Chan WW.
    J Clin Gastroenterol; 2024 Mar 01; 58(3):242-246. PubMed ID: 36943488
    [Abstract] [Full Text] [Related]

  • 12. Proton pump inhibitor therapy reverses endoscopic features of fibrosis in eosinophilic esophagitis.
    Navarro P, Laserna-Mendieta EJ, Guagnozzi D, Casabona S, Perelló A, Savarino E, de la Riva S, Olalla JM, Ghisa M, Serrano-Moya N, Alcolea-Valero C, Ortega-Rabbione G, Majano P, Santander C, Arias Á, Lucendo AJ, EUREOS EoE CONNECT research group.
    Dig Liver Dis; 2021 Nov 01; 53(11):1479-1485. PubMed ID: 34120859
    [Abstract] [Full Text] [Related]

  • 13. High Prevalence of Response to Proton-pump Inhibitor Treatment in Children With Esophageal Eosinophilia.
    Gutiérrez-Junquera C, Fernández-Fernández S, Cilleruelo ML, Rayo A, Echeverría L, Quevedo S, Bracamonte T, Román E.
    J Pediatr Gastroenterol Nutr; 2016 May 01; 62(5):704-10. PubMed ID: 26513622
    [Abstract] [Full Text] [Related]

  • 14. Esophageal eosinophilic infiltration responds to proton pump inhibition in most adults.
    Molina-Infante J, Ferrando-Lamana L, Ripoll C, Hernandez-Alonso M, Mateos JM, Fernandez-Bermejo M, Dueñas C, Fernandez-Gonzalez N, Quintana EM, Gonzalez-Nuñez MA.
    Clin Gastroenterol Hepatol; 2011 Feb 01; 9(2):110-7. PubMed ID: 20920599
    [Abstract] [Full Text] [Related]

  • 15. Esophageal epithelial immunoglobulin G is an important marker for the diagnosis and management of pediatric eosinophilic esophagitis.
    Rizvi SA, Oriala C, Irastorza LE, Bornstein J, Li S, Smadi Y.
    JGH Open; 2022 Jun 01; 6(6):402-407. PubMed ID: 35774352
    [Abstract] [Full Text] [Related]

  • 16. Markers of eosinophilic inflammation for diagnosis of eosinophilic esophagitis and proton pump inhibitor-responsive esophageal eosinophilia: a prospective study.
    Dellon ES, Speck O, Woodward K, Covey S, Rusin S, Gebhart JH, Chen X, Woosley JT, Shaheen NJ.
    Clin Gastroenterol Hepatol; 2014 Dec 01; 12(12):2015-22. PubMed ID: 24993367
    [Abstract] [Full Text] [Related]

  • 17. ACCURACY OF THE EOSINOPHILIC ESOPHAGITIS ENDOSCOPIC REFERENCE SCORE IN CHILDREN.
    Ribeiro LM, Vieira MC, Truppel SK, Rosário Filho NA.
    Arq Gastroenterol; 2024 Dec 01; 61():e23103. PubMed ID: 38451662
    [Abstract] [Full Text] [Related]

  • 18. A multicenter study on the prevalence of eosinophilic esophagitis and PPI-responsive esophageal eosinophilic infiltration.
    Fujiwara Y, Sugawa T, Tanaka F, Tatsuwaki H, Okuyama M, Hayakawa T, Yamamori K, Wada R, Ohtani K, Uno H, Tanigawa T, Watanabe Y, Tominaga K, Watanabe T, Takaishi O, Saeki Y, Nebiki H, Oshitani N, Sato H, Arakawa T.
    Intern Med; 2012 Dec 01; 51(23):3235-9. PubMed ID: 23207117
    [Abstract] [Full Text] [Related]

  • 19. Endoscopic and histological characteristics in patients with eosinophilic esophagitis responsive and non-responsive to proton pump inhibitors.
    Vieira GG, Ribeiro LBM, Truppel SK, Rosário Filho NA, Vieira MC.
    J Pediatr (Rio J); 2020 Dec 01; 96(5):638-643. PubMed ID: 31361987
    [Abstract] [Full Text] [Related]

  • 20. Marked deposition of eosinophil-derived neurotoxin in adult patients with eosinophilic esophagitis.
    Kephart GM, Alexander JA, Arora AS, Romero Y, Smyrk TC, Talley NJ, Kita H.
    Am J Gastroenterol; 2010 Feb 01; 105(2):298-307. PubMed ID: 19888203
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.